China Universal Asset Management Co., Ltd. Autolus Therapeutics PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 40,273 shares of AUTL stock, worth $63,631. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,273
Previous 40,200
0.18%
Holding current value
$63,631
Previous $62,000
46.77%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$42.9 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$32.4 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$26.8 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$26.6 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$26.3 Million98.24% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $144M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...